Flagship Biotech International Profile
Key Indicators
- Authorised Capital ₹ 1.08 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.33 M
as on 16-11-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.58 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.10 Cr
as on 16-11-2024
- Revenue -16.31%
(FY 2023)
- Profit -36.48%
(FY 2023)
- Ebitda -46.09%
(FY 2023)
- Net Worth 22.20%
(FY 2023)
- Total Assets 6.45%
(FY 2023)
About Flagship Biotech International
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.08 Cr and a paid-up capital of Rs 1.33 M.
The company currently has active open charges totaling ₹12.58 Cr. The company has closed loans amounting to ₹5.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Patel, Dipaben Patel, Tejaswini Vidwans, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120MH2011PTC220700
- Company No.
220700
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Flagship Biotech International Private Limited offer?
Flagship Biotech International Private Limited offers a wide range of products and services, including Common Disease Medicines, Nasal Drops, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Laxatives, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Flagship Biotech International?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Patel  | Director | 09-Aug-2011 | Current |
| Kedar Vidhwans | Director | 09-Aug-2011 | Current |
| Dipaben Patel | Director | 09-Aug-2011 | Current |
| Tejaswini Vidwans | Director | 09-Aug-2011 | Current |
Financial Performance of Flagship Biotech International.
Flagship Biotech International Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.31% decrease. The company also saw a substantial fall in profitability, with a 36.48% decrease in profit. The company's net worth Soared by an impressive increase of 22.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Flagship Biotech International?
In 2023, Flagship Biotech International had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Divine Laboratories Pvt. Ltd.Active 30 years 8 monthsShailesh Patel and Kedar Vidhwans are mutual person
- Flagship Ingrevia Private LimitedActive 3 years 7 months
Shailesh Patel and Kedar Vidhwans are mutual person
- Flagship Biotech FoundationActive 11 months 2 days
Shailesh Patel, Dipaben Patel and 2 more are mutual person
- Brigid Wellness Private LimitedActive 4 years 14 days
Tejaswini Vidwans and Kedar Vidhwans are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Sep 2024 | ₹7.10 M | Open |
Others Creation Date: 30 Sep 2024 | ₹4.29 Cr | Open |
Axis Bank Limited Creation Date: 28 Aug 2018 | ₹4.00 Cr | Open |
How Many Employees Work at Flagship Biotech International?
Flagship Biotech International has a workforce of 99 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Flagship Biotech International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flagship Biotech International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
